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Abstract
The medial habenula (MHb) exhibits exceptionally high levels of nicotinic acetylcholine receptors
(nAChRs), but it remains unclear whether all expressed nAChR subunit mRNAs are translated to
form functional receptors. In particular α4 subunits have not been reported to have any functional
role, despite strong α4 mRNA expression in the ventrolateral MHb. We studied a strain of knock-in
mice expressing fluorescent α4* nAChRs (α4YFP), as well as a knock-in strain expressing
hypersensitive α4* nAChRs (α4L9′A). In α4YFP mice, there was strong fluorescence in the
ventrolateral MHb. In hypersensitive α4L9′A mice, injections of a low dose of nicotine (0.1 mg/kg)
led to strong c-fos expression in only the ventrolateral region of the MHb, but not in the MHb of
wild-type (WT) mice. In MHb slice recordings, ventrolateral neurons from α4L9′A mice, but not
from WT mice, responded robustly to nicotine (1 μM). Neurons in the medial aspect of the MHb had
>10-fold smaller responses. Thus α4*-nAChRs contribute to the selective activation of a subset of
MHb neurons. Subunit composition analysis based on gain-of-function knock-in mice provides a
useful experimental paradigm.
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Introduction
Nicotinic acetylcholine receptors (nAChRs) are promising drug targets in the treatment of
several CNS disorders such as Alzheimer's disease, schizophrenia, neuropathic pain and
substance abuse (Arneric et al., 2007). Successful treatments will require discovery of agents
that select among multiple subtypes of nAChRs (Role, 1992; Gotti et al., 2007). To choose
appropriate drugs and to avoid off-target effects, one must understand how each nAChR is
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distributed among cell types and contributes to neuronal function and behavior. Despite much
progress (e.g. Luetje, 2004), these tasks remain challenging because we lack tools to
unambiguously identify the subunit make-up of particular nAChRs. Novel subunit-specific
toxins (Janes, 2005) and gene-specific knockout models (Cordero-Erausquin et al., 2000;
Picciotto et al, 2001) have confirmed roles for certain subunits; however, the expression of
multiple subunits within individual cells renders subunit compensation a possibility in knock-
out studies (e.g., Brussaard, 1994).
Definitive identification of nAChR subtypes is especially problematic for neurons in the medial
habenula (MHb), which expresses the highest levels of nAChRs in the brain (Marks et al.,
1998). MHb expresses mRNAs encoding several different subunits (α3-α7 and β2-β4)
(Sheffield et al., 2000). Pharmacological data suggest that heteromeric nAChRs, composed of
a minimum of α3 and β4 subunits (α3β4*), are a major functional subtype in this nucleus
(Mulle and Changeux, 1990; Quick et al., 1999; Perry et al., 2002; Whiteaker et al., 2002).
While the function(s) of this small epithalamic nucleus is not well understood (Lecourtier and
Kelly, 2007), α3β4*-nAChRs are important for sensitization and self-administration of opioids
in rats (Glick et al., 2006; Taraschenko et al., 2007). It is not yet known how other nAChR
subunits contribute to the heterogeneous MHb nAChR receptor population (Connolly et al.,
1995). This paper examines the expression of functional α4 subunits, whose mRNA is also
found within the MHb (Wada et al, 1989; Pauly et al., 1996). α4* nAChRs are thought to be
necessary and sufficient for the expression of behaviors underlying nicotine addiction including
reward, tolerance and sensitization (Tapper et al., 2004, Maskos et al., 2005), but not
withdrawal (Salas et al, 2004). Also, α4β2* receptors are associated with monogenic epilepsies
(Phillips et al., 1995, Fonck et al., 2003, 2005).
Here we combined conventional approaches with genetic strategies that use two lines of knock-
in mice. One line expresses fluorescently-tagged α4* nAChRs (α4YFP, Nashmi et al., 2007);
the other expresses hypersensitive α4* nAChRs bearing a leucine to alanine substitution at the
M2 9′ position; (α4L9′A, Tapper et al., 2004; Fonck et al, 2005). The results show the
distribution and function of MHb α4* nAChRs.
Materials and Methods
Experiments involving mice were performed following the guidelines established by each
institution's Animal Care Committee. Mutant mouse lines were genotyped by PCR analysis of
tail DNA.
In situ hybridization of the α4 subunit mRNA in MHb of C57BL/6J mice
A mouse DNA template encoding the third intracellular loop of the α4 nAChR subunit was
prepared by RT-PCR amplification of mRNA from a mouse septal neuroblastoma cell line
(SN56). The mouse DNA templates were subcloned into pBluescript SK(+) and sequenced.
The genomic DNA region for α4 had a total of 743 bp (bases 1046–1789). cRNA riboprobes
labeled with [35S]UTP (Dupont NEN, Boston, MA) were synthesized from the mouse DNA
templates. Post-fixed 20 μm sections from C57BL/6J mouse brains were processed for in
situ hybridization. Slide-mounted sections were pre-incubated with 1 μg/ml proteinase K for
10 min at 22°C, then incubated for 18 h at 60 °C with a hybridization solution containing
[35S]UTP-labeled cRNA riboprobe (1×107 cpm/ml) in the antisense or sense orientation. The
sense riboprobe gave no signal above background (not shown). Sections were Nissl stained
(0.1% cresyl violet solution, Sigma-Aldrich, Saint-Louis, MO) to help visualize the MHb.
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Generation and analysis of α4YFP mice
Generation and phenotypic characterization of α4YFP knock-in mice have been described
(Nashmi et al 2007). Previous studies in vitro (Nashmi et al, 2003) and in the knock-in mice
(Nashmi et al, 2007) showed that YFP inserted in the M3-M4 cytoplasmic loop did not alter
the function or distribution of α4* receptors compared to WT. For fluorescence analysis, mice
were sacrificed and fixed by intracardial perfusion with 4% paraformaldehyde in phosphate-
buffered saline (PBS). Brain coronal sections, 30 μm thick, were sliced with a cryostat and
mounted onto glass slides. Sections of the middle portion of the MHb along its rostro-caudual
axis were selected for these studies. Fluorescence images were collected from a microscope
equipped with a spectrally resolved detector array (LSM 510 Meta; Zeiss, Germany). Images
(12-bit intensity resolution over 1024 × 1024 pixels) were collected at wavelengths between
495 and 602 nm with bandwidths of 10.7 nm during excitation of YFP with the 488 nm line
of an argon laser (1-10%; 23 – 114 μW). Specific YFP fluorescence was isolated from
background autofluorescence at each pixel with a linear unmixing algorithm based on two
reference spectra: fluorescence of YFP and autofluorescence of WT brain sections.
C-fos immunoreactivity in nicotine-injected mice
Generation and phenotypic characterization of α4L9′A mice have been previously described
(Tapper et al, 2004, Fonck et al, 2005, Shao et al, 2008). WT and homozygous α4L9′A mice
were subcutaneously injected with 0.1 (n = 5 / genotype), 2 (n = 3 / genotype) or 10 (n = 3 WT)
mg/kg nicotine 1.5 h prior to being euthanized with 2-bromo-2-cloro-1,1,1,-trifluoroethane.
As a negative control, three WT and three α4L9′A mice were injected with saline 1.5 hr prior
to euthanasia. Mice were perfused through the left ventricle with 0.1% heparin in PBS (10 ml)
followed by 4% paraformaldehyde (20 ml). Brains were equilibrated in 25% sucrose before
30 μm thick coronal sections were cut with a cryostat. Brain sections from α4L9′A and WT
mice were simultaneously processed. Free-floating sections were reacted against c-fos
polyclonal antibody diluted 1:500 (Santa Cruz biotechnology, CA). The antigen-antibody
signal was detected with a secondary antibody, amplified with an avidin-biotin reaction (Vector
laboratories, Burlingame, CA) and visualized with diaminobenzidine (Sigma-Aldrich, Saint
Louis, MO).
Initial observations indicated that the distribution pattern of c-fos positive cells was similar
among sections from the rostral, middle and caudal regions of the MHb. Thus final
quantification and statistical analysis were performed on matching (WT vs. α4L9′A) sections
from the middle portion of the MHb, as for the fluorescence measurements on α4YFP mice.
We compared two cell-counting methodologies: i) unbiased stereology using Stereo
Investigator software (mbf-bioscience, Williston, VT) and ii) direct cell counting. The average
number of c-fos positive cells counted within MHb sections was similar for the two methods.
However, the standard deviation rendered by the unbiased stereology method was larger
compared to direct counts. Unbiased stereology contributed more variability to our
measurements because there was an uneven distribution of c-fos positive cells in the MHb. In
other words, there were cell counts from quadrants in regions with many c-fos positive cells
as well as counts from quadrants with very few or no positive cells. Consequently, we
performed our analysis based on direct cell counts. Because the variance in the data was not
randomly distributed in the saline-treated groups, a non-parametric test, Kruskal-Wallis,
followed by Tukey's test for comparisons, was used to compare treatment groups (SigmaStat
by Systat, San Jose CA).
Patch-clamp recording in brain slices
WT and homozygous α4L9′A mice were anesthetized with CO2 and decapitated. Brains were
removed and a block of tissue containing the habenula was placed in ice-cold artificial
cerebrospinal fluid (ACSF) containing in mM: NaCl, 126; NaHCO3, 26; KCl, 2.5;
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NaH2PO4, 1.25; MgCl2, 1; CaCl2, 2; D-glucose, 25; kynurenic acid, 1; bubbled with 95%
CO2 / 5% O2. The tissue was glued to the slicing platform of a DSK-1000 vibratome tissue
slicer (Dosaka EM, Kyoto, Japan), and immersed in ACSF. Four to six coronal slices containing
the MHb were maintained for 1 - 8 h in the pre-chamber, then individually transferred to a
recording chamber mounted to the fixed stage of an Olympus microscope equipped with DIC
optics and an infra-red-sensitive camera and continuously perfused with ACSF at 1–2 ml
min-1.
MHb cell recordings were obtained from either the ventromedial area close to the 3rd ventricle
or the ventrolateral area adjacent to the lateral habenula (see fluorescence in figure 1). Patch
pipettes contained in mM: K- or Cs-gluconate, 144; HEPES, 10; EGTA, 0.2; MgCl2, 3; pH
7.2. Series resistance (uncompensated) and whole-cell capacitance were monitored throughout
the recording. Voltage-clamp currents were recorded using an AxoPatch (Molecular Devices
Axon Instruments) amplifier, filtered at 1 kHz, digitized at 2 kHz and stored to disk using
pCLAMP (Axon) for off-line analysis. Neurons were included in the analysis if there was <
100 pA leak at −50 mV. Nicotine (diluted in ACSF) was applied by pressure ejection (1 - 3
psi, 10 s) using a micropipette positioned < 20 μm from the cell. In some experiments, blockers
were added to the ACSF to suppress other responses: tetrodotoxin (200 nM); D-AP5 (10-20
μM); CNQX (10 μM).
Results
Distribution of α4 mRNA and expression of α4-YFP receptors
The distribution of α4 mRNA and α4 protein was assessed by in situ hybridization in C57BL/
6J mice and by fluorescence of tissue from α4YFP mice, respectively. The signal from
hybridized α4 mRNA was concentrated in the ventrolateral region of the MHb, whereas no
signal was detected in the dorsal-medial aspect of the structure (Figure 1 A, B). A similar
distribution pattern of α4 mRNA within the MHb of C57BL/6J mice appears in the data of
Wada et al (1989) and of the Allen Brain Atlas (www.brain-map.org).
The brains of α4YFP mice displayed YFP signal in several areas (Nashmi et al, 2007). The
highest intensity was found in the MHb. YFP fluorescence was localized to the ventrolateral
portion of the MHb, with a distribution pattern strongly resembling that of the in situ
hybridization study (Figure 1 C, E). α4* nAChRs were also visualized in projection fibers of
the fasciculus retroflexus (fr; Figure 1C, D); other images show that the YFP-fluorescence
persists as these fibers reach the interpeduncular nucleus. As negative control, tissue from WT
littermates of α4YFP mice showed no YFP fluorescence (data not shown).
The α4YFP mice were developed, and have been previously exploited, to provide quantitative
data about protein levels. Thus, when α4YFP expression in various brain areas (Nashmi et al
2007) is compared with the known expression of L-[3H]nicotine binding in those same brain
regions (Marks et al 1992), α4YFP expression correlates significantly with nicotine binding (r
= 0.80; p = 0.0005; Fig. 2A), as expected if α4 subunits are a major component of high affinity
nicotine binding sites (Marks et al., 1992). Furthermore, in detailed previous studies of
midbrain GABAergic neurons, chronic nicotine produced 30-50% increases in α4YFP
fluorescence, and this corresponded well with electrophysiologically measured increases in
nAChR responses (Nashmi et al, 2007). Indeed, Nashmi et al (2007) pointed out that there is
a correlation coefficient, across nine brain areas, of 0.91 between the percentage upregulation
of fluorescence and the percentage upregulation of nicotine binding (Marks et al, 1992; Nashmi
et al, 2007). As observed here for α4 nAChR subunits, there is often a nonlinear or non-
monotonic relation between mRNA expression and protein expression (Fig. 2B). Overall, the
high levels of both α4 mRNA and α4YFP fluorescence suggest that, in the MHb, α4 protein
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distribution closely parallels the expression of α4 subunit mRNA, and also suggest that the
α4 subunit may be functionally incorporated into nAChRs within distinct regions of the MHb.
If α4 subunits normally contribute to receptors in the ventrolateral MHb then one expects cells
in this region to produce especially sensitive nicotine responses in mice carrying the α4L9′A
allele (Tapper et al., 2004). This hypothesis was tested by assaying low dose nicotine-induced
c-fos expression in vivo and low concentration nicotine-evoked currents in slices.
C-fos activation in the MHb of α4L9′A mice
We assessed c-fos expression in brain sections of WT and α4L9′A mice by
immunohistochemical detection. Consistent with its role as a transcription factor, c-fos
expression was revealed by the accumulation of chromophore inside cell nuclei. At a dose of
0.1 mg/kg nicotine, the most conspicuous c-fos signal in the brains of α4L9′A mice was found
in the MHb. Within the MHb, the ventrolateral portion displayed a high density of c-fos positive
cells (119 ± 23 cells/MHb-section), while the more dorsomedial aspects were almost devoid
of labeled cells (Figure 3). The MHb of WT mice injected with 0.1 mg/kg nicotine showed
very few c-fos positive cells (4.4 ± 2.8 cells/MHb-section). Similar to WT injected with 0.1
mg/kg nicotine, low numbers of c-fos positive cells were found in the MHb of both WT and
α4L9′A mice injected with saline solution (WT: 7.0 ± 1.4, α4L9′A: 4.3 ± 1.1 cells/MHb-
section). A dose of 0.1 mg/kg nicotine elicited no observable behavioral effects in WT, while
some (2 out of 5) α4L9′A mice injected with the same dose displayed Straub tail (curving of
the tail over the back).
In α4L9′A mice, nicotine injections at doses higher than > 0.1 mg/kg revealed heavier and
more widespread c-fos labeling in the MHb (Fig. 4) as well as in other brain regions. Thus, at
10 mg/kg, all regions of the MHb from WT mice showed c-fos labeling (Fig. 4C). At the
intermediate dose of 2 mg/kg, dorsomedial cells of the MHb were still much more heavily
labeled in MHb of L9′A than of WT mice (Figure 4A, B). These data imply that, in WT mice,
despite possible differences in subunit composition, nAChRs in all parts of the ventral MHb
are equally sensitive to threshold concentrations of nicotine (see also electrophysiological
evidence in Fig. 5; Quick et al., 1999). However, interpretation of data at these higher doses
of nicotine is likely complicated by previously reported motor responses such as stereotypy
and tremors (Fonck et al, 2005). Correlations between c-fos expression in the brains of α4L9′
A mice and the resulting behavioral responses (for example, seizures at 1 mg/kg nicotine) will
be the subject of a separate study. Young (P14 to P20, similar to animals used for
electrophysiology) α4L9′A (n = 3) and WT mice (n = 2) were analyzed for c-fos expression in
the MHb following a 0.1 mg/kg nicotine injection, revealing a similar expression pattern to
that of adult mice (data not shown).
Patch-clamp recording in the MHb of α4L9′A mice
In neurons from the MHb of WT mice, a low concentration of nicotine (1 μM) evoked small
inward or no currents at holding potentials of -50 to -90 mV, irrespective of the location of the
cell. Figures 5A, B show exemplar traces; and Figure 5C shows all data. These findings indicate
that all neurons in the WT ventral MHb have roughly equal sensitivity to a low concentration
(1 μM) of agonist (see Quick et al., 1999), but provide no information on differential subunit
composition of nAChRs. If, however, α4 subunits participate in a functional receptor
population, we would expect larger responses in α4L9′A mice. This result was indeed realized.
In slices obtained from the α4L9′A animals, all ventrolateral MHb cells showed greatly
enhanced responses to 1 μM nicotine (Figure 5A, right trace; Figure 5C); but ventromedial
MHb cells (Figure 5B, right trace), displayed currents not significantly different in amplitude
from ventromedial MHb cells in WT mice (Figure 5C). These data are consistent with the
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inclusion of α4 subunits into functional nAChRs on cells in the ventrolateral but not the
ventromedial parts of the MHb.
Discussion
These studies illustrate how genetic approaches using knock-in mice that express fluorescent
or hypersensitive nicotinic receptors can help identify the functional contribution of individual
subunit genes to heteromultimeric receptors in specified neurons. Our results indicate that
functional nAChRs containing α4 subunits are selectively localized to cells in the ventrolateral
region of the MHb. This conclusion is based on a consistent set of four observations: the patterns
of α4 mRNA labeling in WT MHb; the patterns of highly sensitive nicotine-induced c-fos
reactivity in MHb neurons from mice expressing hypersensitive α4L9′A subunit genes; the
patterns of highly sensitive nicotine-elicited currents in MHb neurons from mice expressing
hypersensitive α4L9′A subunit genes; and the distribution of YFP-tagged α4* nAChRs in
α4YFP mice. Previous data on the two knock-in lines provide ample assurance that neither the
hypersensitive L9′A mutation nor the introduced YFP moiety alter the expression patterns of
α4* nAChRs or the incorporation of α4 subunits into nAChRs (Tapper et al., 2004; Fonck et
al, 2005; Tapper et al, 2007; Nashmi et al, 2007; Shao et al., 2008). Subunit composition
analysis based on gain-of-function knock-in may be extended to other nAChR subunit genes
or other ligand-gated ion channels.
These gain-of-function analyses complement pharmacological studies, especially because
there are few agonists, antagonists, or allosteric modulators selective for single nAChR
subtypes. The MHb is among a group of brain regions that may not express the otherwise
dominant α4β2* nAChR subtype(s) (Marks et al., 1998; Perry et al., 2002). Previous studies
concluded that a plurality of receptors in this nucleus contain an α3β4 ligand-binding interface,
based on the strong potency of cytisine (Mulle and Changeux, 1990), and the high sensitivity
to the α-conotoxin AuIB (Quick et al., 1999). The present data suggest the presence of an
additional component: an α4* population of nAChRs within the ventrolateral MHb. The c-fos
stereology data, combined with the knowledge that the MHb is ∼1.8 mm in length, allow us
to estimate that this population is ∼7200 neurons per mouse MHb. Which non-α subunit(s)
partner with MHb α4 to form functional receptors? The α4β2 subunit combination, widely
distributed in the rest of the brain, appears unlikely because β2 knockout mice retain nicotinic
responses in MHb (Picciotto et al., 1995). Given the preponderance of β4 in the MHb, we
speculate that α4β4* receptors predominate in the ventrolateral MHb, while the α3β4* subtype
(s) is more prevalent in the medial MHb.
The α4L9′A mice are an exon replacement knock-in strain and do not overexpress receptors.
As shown by Tapper et al (2004) and by Fonck et al (2005), α4L9′A are present at normal to
modestly less than normal levels; non-cytisine-sensitive high-affinity receptors are also present
at normal levels. The α4L9′A mice develop normally in all respects. While they are
hypersensitive to exogenously administered nicotine, ACh itself is eliminated within ∼1 ms
by endogenous acetylcholinesterase. Consistent with these points, previous data show that the
alpha4L9′A mice have only subtly changed baseline physiology, such as a dihydro-β-
erythroidine-sensitive breathing frequency (Shao et al, 2008). It is therefore unlikely that
functional compensation occurs in the medial habenula of the α4L9′A strain by alterations in
the expression of other receptors or subunits.
Interestingly, the major projections of the ventral part of the MHb to the interpeduncular
nucleus (IPN) can be divided roughly in keeping with our suggested distribution of α4* and
non-α4* receptor subtypes. There is a striking retrograde labeling of the ventrolateral MHb
that parallels the fluorescent staining (fr; Figure 1C) after the caudal/lateral parts of the IPN
are injected with dye (Contestabile and Flumerfelt, 1981). This appears to be the dominant
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MHb projection to the IPN, whereas the more medial cell populations seem to project to the
central parts of the IPN (Contestabile and Flumerfelt, 1981). Thus activation of the different
nAChRs regions of the MHb may be associated with differential activation of the subnuclear
regions of the IPN, with a corresponding heterogeneity of physiological and behavioral effects
(Morley, 1986)
Overall, the functional relevance of the MHb is not well understood, although given the
cholinergic phenotype of cells in ventral portions of this nucleus, it is likely to be involved in
behavioral processes, such as reward, sleep-wake cycles and learning and memory, that involve
the relay of cholinergic information from the forebrain to the midbrain (Woolf & Butcher,
1985; Lecourtier and Kelly 2007). Perhaps the differential expression of nAChR subtypes
within medial and lateral regions of the MHb, coupled with distinct efferent targets, allows the
MHb-IPN system to organize these different behaviors. For example, it is tempting to speculate
that the presence of two distinct β4-containing receptors in the medial and lateral MHb may
segregate distinct aspects of addiction, e.g., sensitization, drug-seeking and modulation of
withdrawal symptoms (Salas et al, 2003; Salas et al., 2004; Glick et al., 2006; Taraschenko et
al., 2007).
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Figure 1.
In situ hybridization of α4 subunit mRNA and α4YFP fluorescence in MHb.
A cRNA ribo-probe labeled with [35S]UTP was synthesized from the mouse DNA template.
(A) Approximately a third of the MHb, the ventrolateral aspect, is strongly labeled by the α4
probe. (B) Same section as in (A) stained with Nissl. (C) Confocal image of an α4YFP mouse
brain section with positive YFP fluorescence in the ventrolateral portion of MHb. α4YFP is
also visible in axons of the fasciculus retroflexus fiber tract (fr). (D) Positive YFP fluorescence
on a cross-section of the fasciculus retroflexus fiber track (oval shaped). (E) High-power image
showing α4YFP in individual MHb neurons. (F) Spectrum (wavelength versus YFP intensity)
of the fluorescence from the MHb of an α4YFP mouse brain section indicating specific YFP
signal.
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Figure 2.
Relationship between α4YFP fluorescence and nAChR mRNA and protein levels.
Plots of nicotine binding versus α4YFP fluorescence (A) and α4 nAChR mRNA versus α4YFP
fluorescence (B) for various brain regions including a linear regression fit (solid line) and the
95% confidence intervals (lighter lines). Nicotine binding and α4 mRNA expression over
various brain regions were taken from Marks et al (1992). α4YFP fluorescence expression
measurements were taken from Nashmi et al (2007). Point representing the MHb is shown by
the open symbol. Nicotine binding shows a significant positive correlation (r = 0.80; p = 0.0005)
with α4YFP fluorescence. α4 mRNA did not correlate significantly (r = 0.55; p = 0.08) with
α4YFP fluorescence.
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Figure 3.
C-fos immunoreactivity in WT and α4L9′A mice.
(A) Bright-field image of a coronal section of a WT mouse injected with 0.1 mg/kg nicotine
showing very few c-fos labeled cells in the MHb. (B) The same section as (A) but at higher
magnification. (C) C-fos immunoreactivity in MHb of an α4L9′A mouse injected with 0.1 mg/
kg nicotine. Several c-fos-positive neurons are concentrated in the ventrolateral aspect of the
MHb. (D) The same section as (C), but at higher magnification. (E) The average number of c-
fos-positive cells within the MHb (per brain section) of mice treated with either 0.1 mg/kg
nicotine or saline. There is a significant difference in the average number of c-fos labeled cells
between WT and α4L9′A following a 0.1 mg/kg nicotine injection (Tukey's test, * P < 0.0001).
Error bars indicate the S.E.M.
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Figure 4.
C-fos immunoreactivity in WT and α4L9′A mice following treatment with high concentrations
of nicotine.
Bright-field images of coronal sections of WT (A) or α4L9′A (B) mice injected with 2 mg/kg
nicotine showing differences in the number of c-fos labeled cells especially in the ventrolateral
aspect of the MHb. Bright-field images of coronal sections of WT (C) mice injected with 10
mg/kg nicotine showing extensive c-fos labeling throughout the ventral portion of the MHb.
All animals experienced seizures at the 10 mg/kg dose of nicotine, (α4L9′A but not WT mice
died following seizures and their brains were not processed further for c-fos). The α4L9′A but
not WT mice exhibited seizures at 2 mg/kg (see Fonck et al., 2005).
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Figure 5.
Comparison of nAChR function in MHb neurons from wild-type and α4L9′A mice.
Examples of currents evoked by 1 μM nicotine (10 s puffs) in lateral (A) or medial (B) MHb
cells from WT (left traces) and α4L9′A (right traces) mice. Holding potential was -50 mV. (C)
Scatter plot showing the distribution of current amplitudes. Open circles indicate the mean
current for an individual cell. Filled circles show the group mean. Error bars indicate the S.E.M.
Numbers in parentheses represent the number of cells.
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